Inventor · disambiguated record
Matthew Dowling
Also filed as: DOWLING MATTHEW · DOWLING MATTHEW B
15 granted patents·18 pending applications·125 citations·filing 2008–2024
93Inventor score
Top patents by PatentIndex Score
33 records- 0196US11787922B2Hydrophobically modified chitosan compositionsMEDCURA INC·Filed 2022·Granted Oct 17, 2023·4 cites·23 claims
- 0294US9616088B2Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cellsUNIV OF MARYLAND OFFICE OF TECH COMMERCIALIZATION·Filed 2014·Granted Apr 11, 2017·21 cites·20 claims
- 0394US8668899B2Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute woundsDOWLING MATTHEW·Filed 2010·Granted Mar 11, 2014·36 cites·26 claims
- 0493US11274194B2Hydrophobically modified chitosan compositionsMEDCURA INC·Filed 2019·Granted Mar 15, 2022·6 cites·24 claims
- 0592US11298517B2Advanced functional biocompatible foam used as a hemostatic agent for non-compressible acute woundsUNIV MARYLAND·Filed 2019·Granted Apr 12, 2022·5 cites·8 claims
- 0691US10179145B2Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cellsUNIV MARYLAND·Filed 2016·Granted Jan 15, 2019·5 cites·12 claims
- 0790US2024101795A1Variable-size hydrophobically-modified polymersMEDCURA INC·Filed 2023·Application pending·0 cites
- 0888US8932560B2Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cellsDOWLING MATTHEW·Filed 2008·Granted Jan 13, 2015·15 cites·3 claims
- 0988US8664199B2Method and system for reversal of interactions between hydrophobically modified biopolymers and vesicles or cell membranesDOWLING MATTHEW·Filed 2011·Granted Mar 4, 2014·13 cites·17 claims
- 1088US2023348699A1Hydrophobically modified chitosan compositionsMEDCURA INC·Filed 2023·Application pending·0 cites
- 1185US10493094B2Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cellsGEL E INC·Filed 2017·Granted Dec 3, 2019·4 cites·18 claims
- 1281US9066885B2Advanced functional biocompatible polymeric matrix containing nano-compartmentsRAGHAVAN SRINIVASA R·Filed 2008·Granted Jun 30, 2015·8 cites·21 claims
- 1381US2022243039A1Variable-size hydrophobically-modified polymersMEDCURA INC·Filed 2022·Application pending·0 cites
- 1479US2025170300A1Hydrophobically-modified biopolymer materialsMEDCURA INC·Filed 2024·Application pending·0 cites
- 1577US8858883B2Method and system for capture and use of intact vesicles on electrodeposited hydrophobically modified biopolymer filmsDOWLING MATTHEW·Filed 2011·Granted Oct 14, 2014·7 cites·20 claims
- 1667US12201742B2Hydrophobically-modified biopolymer materialsMEDCURA INC·Filed 2020·Granted Jan 21, 2025·0 cites·15 claims
- 1767US2019160092A1Advanced Functional Biocompatible Polymeric Matrix Used as a Hemostatic Agent and System for Damaged Tissues and CellsUNIV MARYLAND·Filed 2018·Application pending·0 cites
- 1865US12403157B2System and method to reduce tissue ororgan adhesionMEDCURA INC·Filed 2020·Granted Sep 2, 2025·0 cites·14 claims
- 1965US11534459B2Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfacesEYE CARE INT LLC·Filed 2021·Granted Dec 27, 2022·0 cites·15 claims
- 2065US2020121825A1Variable-size hydrophobically-modified polymersGEL E INC·Filed 2018·Application pending·0 cites
- 2164US2023321145A1Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfacesEYE CARE INT LLC·Filed 2022·Application pending·0 cites
- 2262US2015175714A1Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cellsUNIV MARYLAND·Filed 2015·Application pending·0 cites
- 2362US2015175718A1Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cellsUNIV MARYLAND·Filed 2015·Application pending·0 cites
- 2461US11191781B2Compositions and methods of treating dry eye syndrome and other traumatized non-keratinized epithelial surfacesEYE CARE INT LLC·Filed 2017·Granted Dec 7, 2021·1 cites·15 claims
- 2561US2017326169A1Advanced functional biocompatible polymeric matrix containing nano-compartmentsUNIV MARYLAND·Filed 2017·Application pending·0 cites
- 2661US2022226625A1Advanced functional biocompatible foam used as a hemostatic agent for acute woundsUNIV MARYLAND·Filed 2022·Application pending·0 cites
- 2760US2014188070A1Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute woundsUNIV MARYLAND·Filed 2014·Application pending·0 cites
- 2857US2016213704A1Advanced functional biocompatible polymeric matrix containing nano-compartmentsUNIV MARYLAND·Filed 2015·Application pending·0 cites
- 2956US2017326345A1Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute woundsUNIV MARYLAND·Filed 2017·Application pending·0 cites
- 3049US2024032943A1Vascular bleeding control device and methods of useMEDCURA INC·Filed 2021·Application pending·0 cites
- 3147US2020046870A1Materials comprising hydrophobically-modified biopolymerGEL E LIFE SCIENCES·Filed 2017·Application pending·0 cites
- 3245US2021353501A1Hydrophobically-modified polymer foams and methods of useMEDCURA INC·Filed 2018·Application pending·0 cites
- 3339US2019159992A1Hydrophobically-Modified Chitosan for Use in Cosmetics and Personal Care ApplicationsGEL E INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew Dowling files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →